Patrick Zito
MOHS-Micrographic Surgery · Miami, FLNPI 1689052748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 25.4% of the total. Reporting peaked in 2019 at $903 and has fallen 57.7% since, to $382 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.
Across 42 payments — averaging $45.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$486
- Aerin Medical Inc.$436
- Organogenesis Inc.$147
- Lilly USA, LLC$139
- Almirall LLC$119
- Galderma Laboratories, L.p.$114
- plus $475 from 12 others
What the payments were for
- Food & beverage$1,915100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $486 |
| Aerin Medical Inc. | 3 | $436 |
| Organogenesis Inc. | 6 | $147 |
| Lilly USA, LLC | 4 | $139 |
| Almirall LLC | 1 | $119 |
| Galderma Laboratories, L.p. | 1 | $114 |
| Pfizer | 1 | $107 |
| Novartis | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Kerecis Limited | 1 | $50 |
| Incyte Corporation | 2 | $47 |
| Verrica Pharmaceuticals Inc. | 2 | $41 |
| Amgen | 1 | $28 |
| Smith+Nephew | 1 | $23 |
| Sanofi | 1 | $19 |
| Bristol Myers Squibb | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$436
- RHINAER STYLUS$436
- BOTOX COSMETIC$150
- Seysara$119
- ORACEA$114
- SOOLANTRA$114
- EUCRISA$107
How this compares
$1,915 in reported general payments places this provider in the 50th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 36 | $1,551 |
| Mupirocin | 129 | $884 |
| Ketoconazole | 60 | $752 |
| Ammonium Lactate | 42 | $686 |
| Doxycycline Hyclate | 74 | $575 |
| Doxycycline Monohydrate | 27 | $235 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Miami
- Jennifer TangMiami$17K
- Peter BittarMiami$3K
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.